- call +1-201-465-4211
- email sales@mrinsights.biz
A DNA vaccine is a small, circular DNA plasmid that encode one or more protein antigens under the control of a promoter to produce immune response against disease. DNA vaccines are basically the third generation vaccines that are specifically designed to overcome the unsought properties of conventional vaccines.
Scope of the Report:
This report focuses on the DNA Vaccines in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
The increasing vulnerability of population to infectious diseases and increasing number of antibiotics resistant pathogens have created the need for effective and low-cost vaccination, which would provide long lasting immunity.
The worldwide market for DNA Vaccines is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.
Market Segment by Manufacturers, this report covers
Sanofi Aventis
Pfizer
Novartis
Merck
GlaxoSmithKline
ABL
Immunologicals
Xenetic Biosciences
QED Biosciences
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Human DNA vaccines
Animal DNA vaccines
Market Segment by Applications, can be divided into
Human health
Animal health
Research application
There are 15 Chapters to deeply display the global DNA Vaccines market.
Chapter 1, to describe DNA Vaccines Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of DNA Vaccines, with sales, revenue, and price of DNA Vaccines, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of DNA Vaccines, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, DNA Vaccines market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe DNA Vaccines sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 DNA Vaccines Introduction
1.2 Market Analysis by Type
1.2.1 Human DNA vaccines
1.2.2 Animal DNA vaccines
1.3 Market Analysis by Applications
1.3.1 Human health
1.3.2 Animal health
1.3.3 Research application
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Sanofi Aventis
2.1.1 Business Overview
2.1.2 DNA Vaccines Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Sanofi Aventis DNA Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Pfizer
2.2.1 Business Overview
2.2.2 DNA Vaccines Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Pfizer DNA Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Novartis
2.3.1 Business Overview
2.3.2 DNA Vaccines Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Novartis DNA Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Merck
2.4.1 Business Overview
2.4.2 DNA Vaccines Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Merck DNA Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 GlaxoSmithKline
2.5.1 Business Overview
2.5.2 DNA Vaccines Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 GlaxoSmithKline DNA Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 ABL
2.6.1 Business Overview
2.6.2 DNA Vaccines Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 ABL DNA Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 Immunologicals
2.7.1 Business Overview
2.7.2 DNA Vaccines Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Immunologicals DNA Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 Xenetic Biosciences
2.8.1 Business Overview
2.8.2 DNA Vaccines Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Xenetic Biosciences DNA Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 QED Biosciences
2.9.1 Business Overview
2.9.2 DNA Vaccines Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 QED Biosciences DNA Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global DNA Vaccines Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global DNA Vaccines Sales and Market Share by Manufacturer (2016-2017)
3.2 Global DNA Vaccines Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 DNA Vaccines Manufacturer Market Share in 2017
3.3.2 Top 6 DNA Vaccines Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global DNA Vaccines Market Analysis by Regions
4.1 Global DNA Vaccines Sales, Revenue and Market Share by Regions
4.1.1 Global DNA Vaccines Sales and Market Share by Regions (2013-2018)
4.1.2 Global DNA Vaccines Revenue and Market Share by Regions (2013-2018)
4.2 North America DNA Vaccines Sales and Growth Rate (2013-2018)
4.3 Europe DNA Vaccines Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific DNA Vaccines Sales and Growth Rate (2013-2018)
4.5 South America DNA Vaccines Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa DNA Vaccines Sales and Growth Rate (2013-2018)
5 North America DNA Vaccines by Countries
5.1 North America DNA Vaccines Sales, Revenue and Market Share by Countries
5.1.1 North America DNA Vaccines Sales and Market Share by Countries (2013-2018)
5.1.2 North America DNA Vaccines Revenue and Market Share by Countries (2013-2018)
5.2 United States DNA Vaccines Sales and Growth Rate (2013-2018)
5.3 Canada DNA Vaccines Sales and Growth Rate (2013-2018)
5.4 Mexico DNA Vaccines Sales and Growth Rate (2013-2018)
6 Europe DNA Vaccines by Countries
6.1 Europe DNA Vaccines Sales, Revenue and Market Share by Countries
6.1.1 Europe DNA Vaccines Sales and Market Share by Countries (2013-2018)
6.1.2 Europe DNA Vaccines Revenue and Market Share by Countries (2013-2018)
6.2 Germany DNA Vaccines Sales and Growth Rate (2013-2018)
6.3 UK DNA Vaccines Sales and Growth Rate (2013-2018)
6.4 France DNA Vaccines Sales and Growth Rate (2013-2018)
6.5 Russia DNA Vaccines Sales and Growth Rate (2013-2018)
6.6 Italy DNA Vaccines Sales and Growth Rate (2013-2018)
7 Asia-Pacific DNA Vaccines by Countries
7.1 Asia-Pacific DNA Vaccines Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific DNA Vaccines Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific DNA Vaccines Revenue and Market Share by Countries (2013-2018)
7.2 China DNA Vaccines Sales and Growth Rate (2013-2018)
7.3 Japan DNA Vaccines Sales and Growth Rate (2013-2018)
7.4 Korea DNA Vaccines Sales and Growth Rate (2013-2018)
7.5 India DNA Vaccines Sales and Growth Rate (2013-2018)
7.6 Southeast Asia DNA Vaccines Sales and Growth Rate (2013-2018)
8 South America DNA Vaccines by Countries
8.1 South America DNA Vaccines Sales, Revenue and Market Share by Countries
8.1.1 South America DNA Vaccines Sales and Market Share by Countries (2013-2018)
8.1.2 South America DNA Vaccines Revenue and Market Share by Countries (2013-2018)
8.2 Brazil DNA Vaccines Sales and Growth Rate (2013-2018)
8.3 Argentina DNA Vaccines Sales and Growth Rate (2013-2018)
8.4 Colombia DNA Vaccines Sales and Growth Rate (2013-2018)
9 Middle East and Africa DNA Vaccines by Countries
9.1 Middle East and Africa DNA Vaccines Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa DNA Vaccines Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa DNA Vaccines Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia DNA Vaccines Sales and Growth Rate (2013-2018)
9.3 UAE DNA Vaccines Sales and Growth Rate (2013-2018)
9.4 Egypt DNA Vaccines Sales and Growth Rate (2013-2018)
9.5 Nigeria DNA Vaccines Sales and Growth Rate (2013-2018)
9.6 South Africa DNA Vaccines Sales and Growth Rate (2013-2018)
10 Global DNA Vaccines Market Segment by Type
10.1 Global DNA Vaccines Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global DNA Vaccines Sales and Market Share by Type (2013-2018)
10.1.2 Global DNA Vaccines Revenue and Market Share by Type (2013-2018)
10.2 Human DNA vaccines Sales Growth and Price
10.2.1 Global Human DNA vaccines Sales Growth (2013-2018)
10.2.2 Global Human DNA vaccines Price (2013-2018)
10.3 Animal DNA vaccines Sales Growth and Price
10.3.1 Global Animal DNA vaccines Sales Growth (2013-2018)
10.3.2 Global Animal DNA vaccines Price (2013-2018)
11 Global DNA Vaccines Market Segment by Application
11.1 Global DNA Vaccines Sales Market Share by Application (2013-2018)
11.2 Human health Sales Growth (2013-2018)
11.3 Animal health Sales Growth (2013-2018)
11.4 Research application Sales Growth (2013-2018)
12 DNA Vaccines Market Forecast (2018-2023)
12.1 Global DNA Vaccines Sales, Revenue and Growth Rate (2018-2023)
12.2 DNA Vaccines Market Forecast by Regions (2018-2023)
12.2.1 North America DNA Vaccines Market Forecast (2018-2023)
12.2.2 Europe DNA Vaccines Market Forecast (2018-2023)
12.2.3 Asia-Pacific DNA Vaccines Market Forecast (2018-2023)
12.2.4 South America DNA Vaccines Market Forecast (2018-2023)
12.2.5 Middle East and Africa DNA Vaccines Market Forecast (2018-2023)
12.3 DNA Vaccines Market Forecast by Type (2018-2023)
12.3.1 Global DNA Vaccines Sales Forecast by Type (2018-2023)
12.3.2 Global DNA Vaccines Market Share Forecast by Type (2018-2023)
12.4 DNA Vaccines Market Forecast by Application (2018-2023)
12.4.1 Global DNA Vaccines Sales Forecast by Application (2018-2023)
12.4.2 Global DNA Vaccines Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure DNA Vaccines Picture
Table Product Specifications of DNA Vaccines
Figure Global Sales Market Share of DNA Vaccines by Types in 2017
Table DNA Vaccines T
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
